Waterbury Thomas M, Reeder Guy S, Pislaru Sorin V, Cabalka Allison K, Rihal Charanjit S, Eleid Mackram F
Department of Cardiovascular Diseases, Mayo Clinic, Rochester, Minnesota.
Department of Pediatric and Adolescent Medicine, Division of Pediatric Cardiology, Mayo Clinic, Rochester, Minnesota.
Catheter Cardiovasc Interv. 2017 Nov 1;90(5):870-877. doi: 10.1002/ccd.27224. Epub 2017 Aug 2.
To investigate the feasibility, procedural success, and outcomes of paravalvular leak (PVL) closure in patients with prior transcatheter aortic valve replacement (TAVR).
PVL after TAVR is associated with adverse patient outcomes and increased mortality. Percutaneous PVL closure has emerged as a therapeutic strategy for addressing this issue, but data for transcatheter PVL repair after TAVR remains limited.
This is a single center retrospective review of PVL closure after TAVR. Patients with balloon-expandable or self-expanding prostheses were included. Baseline patient demographics, procedural characteristics, complications, and clinical outcomes were reviewed.
A total of 18 patients with clinically significant PVL after TAVR referred for PVL closure were identified during the study period. Procedural success resulting in successful transcatheter occluder plug delivery was 78% (14 cases). Balloon postdilatation (2/4) and valve-in-valve (2/4) were used effectively in the remaining patients after an unsuccessful PVL closure attempt. PVL grading by echocardiography decreased from moderate or severe to < moderate in 13 patients (72%). Adverse events including cardiac tamponade and acute kidney injury occurred in 1 case each. One-month all-cause mortality was 11%.
In selected patients, percutaneous PVL repair following TAVR is feasible and effective for both balloon-expandable and self-expanding prostheses. Most patients undergoing PVL closure after TAVR require a single occluder plug placement for reduction in PVL to mild or less.
探讨既往经导管主动脉瓣置换术(TAVR)患者行瓣周漏(PVL)封堵术的可行性、手术成功率及预后。
TAVR术后的PVL与患者不良预后及死亡率增加相关。经皮PVL封堵已成为解决这一问题的治疗策略,但TAVR术后经导管PVL修复的数据仍然有限。
这是一项关于TAVR术后PVL封堵的单中心回顾性研究。纳入使用球囊扩张式或自膨式人工瓣膜的患者。回顾患者的基线人口统计学资料、手术特征、并发症及临床预后。
研究期间共确定18例TAVR术后有临床显著PVL并转诊行PVL封堵的患者。手术成功(即成功经导管输送封堵器)率为78%(14例)。在PVL封堵尝试失败后的其余患者中,有效使用了球囊后扩张(2/4)和瓣中瓣(2/4)技术。13例患者(72%)经超声心动图评估的PVL分级从中度或重度降至<中度。不良事件包括心脏压塞和急性肾损伤各发生1例。1个月全因死亡率为11%。
对于部分患者,TAVR术后经皮PVL修复对于球囊扩张式和自膨式人工瓣膜均可行且有效。大多数TAVR术后行PVL封堵的患者只需置入单个封堵器即可将PVL降至轻度或更低。